Moreover, high RASAL2 expression in these cells was strongly associated with a tumour transcriptomic signature [17] derived from genes enriched in residual viable tumour population of patients treated with pre-operative chemotherapy (Fig. 1B). This evidence concerns the gene RASAL2 and neoplasm.